Loading insider details...
Beta
Latest Form 4 (Jun 10, 2026): Grant/Award of 5,778 ARQT shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 10, 2026 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/Award | 5,778 | n/a |
| Nov 18, 2025 | Artiva Biotherapeutics, Inc. (ARTV) | Tax Withholding | 3,490 | $11.3K |
| Nov 18, 2025 | Arcutis Biotherapeutics, Inc. (ARQT) | Exercise/Conversion | 27,052 | $233.5K |
| Aug 19, 2025 | Artiva Biotherapeutics, Inc. (ARTV) | Tax Withholding | 1,341 | $2.9K |
| Jun 17, 2025 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/Award | 7,609 | n/a |
| Feb 28, 2025 | Artiva Biotherapeutics, Inc. (ARTV) | Grant/Award | 60,000 | n/a |
| Sep 13, 2024 | Artiva Biotherapeutics, Inc. (ARTV) | Grant/Award | 50,000 | n/a |
| Jun 18, 2024 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/Award | 10,139 | n/a |
| Apr 5, 2024 | Kinnate Biopharma Inc. (KNTE) | Disposition to Issuer | 64,087 | n/a |
| Mar 5, 2024 | Kinnate Biopharma Inc. (KNTE) | Tax Withholding | 1,506 | $3.9K |